Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Thermo Fisher Scientific TMO +0.14% Get Free Report has outperformed the market over the past 15 years by 6.03% on an ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

We recently published a list of 10 Hottest Mega-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Thermo Fisher TMO has been suffering due to a continuous decline in testing sales. Also, competitive headwinds and currency ...

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership to develop Lyndra's long-acting oral ...

Assenagon Asset Management S.A. cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 61.6% ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

Shares of Thermo Fisher Scientific Inc. TMO inched 0.26% higher to $556.99 Tuesday, on what proved to be an all-around ...